Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
BLISS Mints are a cannabis-based, prescription-grade sublingual Ayurvedic formulation developed by BOHECO (Bombay Hemp Company) to support focus, mental clarity, and manage mild anxiety and everyday stress. Each mint contains 20 mg of cannabidiol (CBD) derived from naturally grown *Cannabis sativa* (Vijaya) leaf extract, combined with traditional Ayurvedic adaptogens and calming botanicals including Ashwagandha (*Withania somnifera*), Brahmi (*Bacopa monnieri*), Tulsi (*Ocimum sanctum*), Chamomile (*Matricaria chamomilla*), and Lavender (*Lavandula angustifolia*). The formulation is designed to interact with the body's endocannabinoid system (ECS) via CB1 and CB2 receptors to regulate the stress response and promote emotional balance without causing intoxication or euphoria.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on BLISS Mints.